Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Products In Brief: MacuDrop, Clearwayz, Adiri MD+ and more

This article was originally published in The Tan Sheet

Executive Summary

Macular Health launches MacuDrop AREDS II; Clearwayz supplement supports sinuses; Supplement beverage for bariatric patients; Adiri MD+ Nurser for accurate dosing; BabyB targets cause of rashes; more New Products In Brief

You may also be interested in...



Firms Sift Eye Study Data For Benefit From Lutein And Zeaxanthin

After the Age-Related Eye Disease Study found lutein, zeaxanthin and omega-3s do not slow age-related macular degeneration, supplement firms revisit the data and find lutein and zeaxanthin could slow the disease in deficient populations.

Infirst Expects Dr. Cocoa OTCs To Win Over Children And Parents

CEO Manfred Scheske believes cocoa flavoring gives Dr. Cocoa an edge in the children’s OTC space, where competitors already offer flavors in many products. Experts says flavors make taking a medicine more appealing to children, but some question whether flavors should be used.

Infirst Expects Dr. Cocoa OTCs To Win Over Children And Parents

CEO Manfred Scheske believes cocoa flavoring gives Dr. Cocoa an edge in the children’s OTC space, where competitors already offer flavors in many products. Experts says flavors make taking a medicine more appealing to children, but some question whether flavors should be used.

Topics

UsernamePublicRestriction

Register

LL1132098

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel